Constitutive activity at serotonin 5-HT1D receptors:: detection by homologous GTPγS versus [35S]-GTPγS binding isotherms

被引:25
作者
Audinot, V [1 ]
Newman-Tancredi, A [1 ]
Millan, MJ [1 ]
机构
[1] Inst Rech Servier, Dept Psychopharmacol, F-78290 Paris, France
关键词
5-HT1D receptor; constitutive activity; S-35]-GTP gamma S; inverse agonist;
D O I
10.1016/S0028-3908(00)00104-0
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Although many G-protein-coupled receptors (GPCRs) may display constitutive activity, their detection has, to date, depended on the use of inverse agonists. The present study exploited a novel procedure:to investigate constitutive activity at recombinant human (h) serotonin (5-HT) 5-HT1D receptors stably expressed in Chinese hamster ovary (CHO) cells. 5-HT modestly stimulated guanosine-5'-0-(3-[S-35]thio)-triphosphate ([S-35]-GTP gammaS) binding to CHO-h5-HT1D membranes whereas methiothepin and the 5-HT1B/1D-selective ligand, SB224,289, exerted robust inhibition of basal [S-35]-GTP gammaS binding (inverse agonism). These actions were specific inasmuch as they were reversed by the novel, selective 5-HT1B/1D ligand, S18127. Constitutive activity was investigated by homologous inhibition of [S-35]-GTP gammaS binding to CHO-h5-HT1D membranes with unlabelled GTP gammaS. Under 'basal' conditions (absence of receptor ligand), biphasic isotherms were observed. Most (80%) [S-35]-GTP gammaS binding sites were in the high affinity (HA) versus low affinity (LA) component of the isotherms. HA binding was augmented by 5-HT (to 155%; relative to basal values=100%), but decreased by methiothepin (to 23%) and by SB224,289 (to 67%). In contrast, LA binding was not altered. Further, membranes of untransfected CHO cells exhibited only LA binding sites, indicating that the latter are not related to h5-HT1D receptor-G-protein coupling. Thus, at 5-HT1D receptors expressed in this CHO cell line, HA binding detected in homologous inhibition experiments (GTP gammaS versus [S-35]-GTP gammaS) under basal conditions provides a measure of constitutive G-protein activation. Thus, it is suggested that for h5-HT1D receptors and, possibly, other GPCRs, inverse agonists will be detectable by [S-35]-GTP gammaS binding if a HA component is present under basal conditions. (C) 2000 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:57 / 64
页数:8
相关论文
共 42 条
  • [1] Binding profile of the novel 5-HT1B/1D receptor antagonist, [H-3]GR 125,743, in guinea-pig brain: A comparison with [H-3]5-carboxamidotryptamine
    Audinot, V
    Lochon, S
    NewmanTancredi, A
    Lavielle, G
    Millan, MJ
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1997, 327 (2-3) : 247 - 256
  • [2] BIRNBAUMER L, 1995, J RECEPT SIGNAL TR R, V15, P213
  • [3] COUPLING OF M-CHOLINOCEPTORS AND A(1) ADENOSINE RECEPTORS IN HUMAN MYOCARDIUM
    BOHM, M
    GIERSCHIK, P
    SCHWINGER, RHG
    UHLMANN, R
    ERDMANN, E
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY, 1994, 266 (05): : H1951 - H1958
  • [4] PHYSIOLOGICAL-EFFECTS OF INVERSE AGONISTS IN TRANSGENIC MICE WITH MYOCARDIAL OVEREXPRESSION OF THE BETA(2)-ADRENOCEPTOR
    BOND, RA
    LEFF, P
    JOHNSON, TD
    MILANO, CA
    ROCKMAN, HA
    MCMINN, TR
    APPARSUNDARAM, S
    HYEK, MF
    KENAKIN, TP
    ALLEN, LF
    LEFKOWITZ, RJ
    [J]. NATURE, 1995, 374 (6519) : 272 - 276
  • [5] Cannabinoid receptor agonist efficacy for stimulating [35S]GTPγS binding to rat cerebellar membranes correlates with agonist-induced decreases in GDP affinity
    Breivogel, CS
    Selley, DE
    Childers, SR
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (27) : 16865 - 16873
  • [6] COSTA T, 1992, MOL PHARMACOL, V41, P549
  • [7] Characterization of human serotonin in and 1B receptors using [H-3]-GR-125743, a novel radiolabelled serotonin 5HT1D/1B receptor antagonist
    Domenech, T
    Beleta, J
    Palacios, JM
    [J]. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1997, 356 (03) : 328 - 334
  • [8] Pharmacological analysis of dopamine stimulation of [S-35]-GTP gamma S binding via human D-2short and D-2long dopamine receptors expressed in recombinant cells
    Gardner, B
    Hall, DA
    Strange, PG
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 1996, 118 (06) : 1544 - 1550
  • [9] The selective 5-HT1B receptor inverse agonist 1′-methyl-5[[2′-methyl-4′-(5-methyl-1,2,4-oxadiazol-3-yl)biphenyl-4-yl]carbonyl]-2,3,6,7-tetrahydrospiro[furo[2,3-f]indole-3,4′-piperidine] (SB-224289) potently blocks terminal 5-HT autoreceptor function both in vitro and in vivo
    Gaster, LM
    Blaney, FE
    Davies, S
    Duckworth, DM
    Ham, P
    Jenkins, S
    Jennings, AJ
    Joiner, GF
    King, FD
    Mulholland, KR
    Wyman, PA
    Hagan, JJ
    Hatcher, J
    Jones, BJ
    Middlemiss, DN
    Price, GW
    Riley, G
    Roberts, C
    Routledge, C
    Selkirk, J
    Slade, PD
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1998, 41 (08) : 1218 - 1235
  • [10] G protein-coupled receptors - II. Mechanism of agonist activation
    Gether, U
    Kobilka, BK
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (29) : 17979 - 17982